Post-approval studies (Phase 4)Ended earlyNCT00787917
What this trial is testing
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)
Who this might be right for
Cystic FibrosisAllergic Bronchopulmonary Aspergillosis
Novartis Pharmaceuticals 14